Imricor Medical Systems Inc
ASX:IMR
Imricor Medical Systems Inc
ASX:IMR
Price:
1.93
AUD
-4.46%
Market Closed
Market Cap:
AU$619.4m
Income Statement
Earnings Waterfall
Imricor Medical Systems Inc
Imricor Medical Systems Inc
Income Statement
Imricor Medical Systems Inc
Imricor Medical Systems Inc
Currency: USD
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
1
+35%
|
1
-19%
|
1
+13%
|
1
-12%
|
1
+25%
|
1
-6%
|
0
-42%
|
1
+29%
|
1
+34%
|
1
+16%
|
1
-22%
|
0
-61%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
(0)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Gross Profit |
0
N/A
|
0
-55%
|
(0)
N/A
|
(1)
-174%
|
(2)
-74%
|
(2)
-4%
|
(2)
+23%
|
(1)
+8%
|
(1)
+21%
|
(1)
+18%
|
(1)
-1%
|
(1)
-8%
|
(2)
-104%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(7)
|
(9)
|
(12)
|
(15)
|
(18)
|
(18)
|
(16)
|
(15)
|
(16)
|
(15)
|
(15)
|
(18)
|
(21)
|
|
| Selling, General & Administrative |
(3)
|
(5)
|
(6)
|
(7)
|
(9)
|
(9)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(8)
|
(10)
|
|
| Research & Development |
(4)
|
(4)
|
(6)
|
(8)
|
(10)
|
(9)
|
(8)
|
(7)
|
(8)
|
(8)
|
(8)
|
(10)
|
(11)
|
|
| Operating Income |
(7)
N/A
|
(9)
-36%
|
(12)
-34%
|
(16)
-37%
|
(20)
-24%
|
(20)
+0%
|
(17)
+15%
|
(17)
+3%
|
(17)
-1%
|
(16)
+6%
|
(16)
-3%
|
(19)
-19%
|
(23)
-18%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(6)
|
(3)
|
(14)
|
(17)
|
(3)
|
|
| Non-Reccuring Items |
(6)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
1
|
1
|
(0)
|
(0)
|
0
|
(1)
|
0
|
1
|
1
|
|
| Pre-Tax Income |
(13)
N/A
|
(14)
-6%
|
(12)
+11%
|
(17)
-33%
|
(20)
-19%
|
(20)
+1%
|
(17)
+11%
|
(17)
+3%
|
(23)
-35%
|
(20)
+10%
|
(30)
-47%
|
(36)
-21%
|
(25)
+30%
|
|
| Net Income | ||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(13)
|
(14)
|
(12)
|
(17)
|
(20)
|
(20)
|
(17)
|
(17)
|
(23)
|
(20)
|
(30)
|
(36)
|
(25)
|
|
| Net Income (Common) |
(13)
N/A
|
(14)
-6%
|
(12)
+11%
|
(17)
-33%
|
(20)
-19%
|
(20)
+1%
|
(17)
+11%
|
(17)
+3%
|
(23)
-35%
|
(20)
+10%
|
(30)
-47%
|
(36)
-21%
|
(25)
+30%
|
|
| EPS (Diluted) |
-0.14
N/A
|
-0.14
N/A
|
-0.11
+21%
|
-0.14
-27%
|
-0.15
-7%
|
-0.14
+7%
|
-0.12
+14%
|
-0.11
+8%
|
-0.14
-27%
|
-0.12
+14%
|
-0.13
-8%
|
-0.13
N/A
|
-0.08
+38%
|
|
Switch to:
Switch to:
See Also
Discover More
